Tocilizumab May Benefit Certain Severe COVID-19 Patients | MedPage Today
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential - Ghasemi - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
Buy RoActemra (tocilizumab) Online • Price & Costs | Everyone.org
Health System News Teamwork Tackles Tocilizumab
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
USTC Global on X: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t.co ...
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
WHO adds Roche's arthritis drug tocilizumab to COVID-19 medicines list | Reuters
Roche won't contest Hetero Drug's tocilizumab copy | Mint
Approval lapsed) RoActemra tocilizumab 200 mg/ 10mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Is PMR the Next Indication for Tocilizumab? | MedPage Today
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Drug vignettes: Tocilizumab - The Centre for Evidence-Based Medicine
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
Roche | Actemra/RoActemra (tocilizumab)
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates - ABC News
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
FDA Advisory No.2021-2407 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Tocilizumab Injection Actemra® 400 mg/ 20 mL” - Food and Drug Administration
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
